Business /

Money

IPO

China vital to Insilico’s plan to build biotech’s AI ‘Einstein’ for new drugs

US firm, backed by Fosun and Tencent, expands research base in China as it develops an AI-powered drug-discovery tool.

Insilico Medicine leads 6 Hong Kong IPOs, capping banner fundraising year

Hong Kong accounting firms plan hiring spree and embrace AI to attract talent

KPMG, Deloitte and EY boost hiring and invest in AI to lift efficiency and attract talent amid rising demand for tech-savvy professionals.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW